XILI TECHNOLOGY(SH:688616)2023-04-26 16:00Financial Performance - The company's operating revenue for 2022 was CNY 542,342,572.11, representing a 32.03% increase compared to CNY 410,776,160.89 in 2021[21]. - The net profit attributable to shareholders for 2022 was CNY 63,638,384.89, a decrease of 9.45% from CNY 70,283,471.28 in 2021[21]. - The basic earnings per share for 2022 was CNY 0.42, down 16.00% from CNY 0.50 in 2021[22]. - The company's total revenue for the year was approximately 535.93 million, with a gross margin of 26.06%, reflecting a year-over-year increase of 33.01% in revenue but a decrease of 6.21 percentage points in gross margin[85]. - The company reported a revenue of 1.2 billion in 2022, representing a year-over-year growth of 15%[138]. - The company reported a revenue increase of 15% year-over-year, reaching RMB 1.2 billion in 2022[142]. Dividend Distribution - The company's distributable profit at the end of 2022 was RMB 224,698,100.64, with a proposed cash dividend of RMB 2.10 per 10 shares, totaling RMB 31,500,000.00, which represents 49.50% of the net profit attributable to shareholders of the parent company[5]. - The total share capital for the dividend distribution is 150,000,000 shares, and the cash dividend is subject to approval at the 2022 annual general meeting[6]. - The cash dividend amount represents 49.50% of the net profit attributable to the parent company's shareholders for the fiscal year[164]. Research and Development - Research and development expenses accounted for 5.41% of operating revenue in 2022, slightly down from 5.50% in 2021[22]. - The company achieved a total R&D investment of ¥29,360,441.11, representing a 30% increase compared to ¥22,585,502.22 in the previous year[58]. - R&D investment accounted for 5.41% of total revenue, slightly down from 5.50% in the previous year[58]. - The company added 2 invention patents, 8 utility model patents, 5 design patents, and 14 software copyrights during the reporting period, totaling 29 new intellectual property rights[56]. - The company is investing 50 million in R&D for new technologies aimed at enhancing user experience[138]. - Research and development expenses increased by 20%, totaling RMB 150 million, focusing on advanced technology solutions[144]. Market Expansion - The company plans to continue expanding its international market presence, contributing to significant growth in export revenue[22]. - The company has expanded its overseas sales by exporting electric meter products to Southeast Asia, South Asia, South America, and Africa through bidding and direct customer development[47]. - Domestic revenue reached approximately 453.61 million, growing by 23.93% year-over-year, while international revenue surged by 123.10% to approximately 82.32 million, indicating successful international market expansion[86]. - The company plans to enhance its overseas market presence and invest in new products and qualification certifications to broaden its sales scope[123]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by 2025[142]. Operational Efficiency - The company has implemented advanced manufacturing systems to ensure high production automation and quality control, improving overall production efficiency[54]. - The company employs an order-based production model, enhancing production efficiency and quality through an MES production execution system integrated with ERP systems[44]. - The company reported a 5% reduction in operational costs due to improved efficiency measures implemented in Q3 2023[140]. - Operational efficiency improvements are expected to reduce costs by approximately 5% over the next year[137]. Risk Management - The company has detailed risk factors in the management discussion and analysis section of the report[4]. - The company faced a risk of reliance on major clients, particularly the State Grid, which could impact performance if demand decreases[73]. - The company has established a comprehensive internal control governance system to protect the rights of shareholders and creditors[190]. - The company emphasizes its commitment to social responsibility by actively participating in public welfare activities, including blood donation campaigns[174]. Corporate Governance - The company has established a comprehensive governance structure to ensure legal compliance and operational standardization[174]. - The board of directors and senior management maintained stable shareholding, with no changes in shareholding for key personnel during the reporting period[136]. - The company has no penalties from securities regulatory agencies in the past three years[148]. - The company has established a comprehensive internal control system that effectively protects asset security and ensures the accuracy of financial reporting[170]. Social Responsibility - The company has established a special charity fund to assist 13 patients with malignant tumors, contributing CNY 49,000 to alleviate their financial burdens[187]. - The company has organized employee participation in blood donation activities for six consecutive years, with a total donation volume of 40,000 milliliters as of the reporting period[188]. - The company has invested CNY 373,600 in environmental protection during the reporting period[176]. - The company has not received any administrative penalties related to environmental issues during the reporting period[177]. Employee Management - The company has a total of 486 employees, with 383 in the parent company and 103 in major subsidiaries[155]. - Total compensation for all directors, supervisors, and senior management at the end of the reporting period amounted to 430.87 million[146]. - Total compensation for core technical personnel at the end of the reporting period was 236.21 million[146]. - The professional composition of employees includes 243 production personnel, 46 sales personnel, 123 technical personnel, 6 financial personnel, and 68 administrative personnel[155].